Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine/Naloxone vs Clonidine for Inpatient Opiate Detoxification
NCT00032955Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- Feb 2001
- Primary completion
- Aug 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started Feb 2001; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00032955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032955.